Call has ended!
The European Partnership for Personalized Medicine (EP PerMed) partnership launched in January 2024. More than 50 partners and financing organisations from different EU countries are involved in the partnership. In Finland, Business Finland participate in the funding in the 2025 call.
The second call of the ten-year program period, Joint Transnational Call (JTC2025) “Pharmacogenomic Strategies for Personalised Medicine (PGxPM2025)”, has opened in December. The preliminary budget for the call is approximately €35 million, of which Business Finland's grant budget is at most €3 million.
Aim of the call
The EP PerMed JTC2025 is co-funded by the EU and the overall objectives of the JTC2025 are to support research projects in human health on pharmacogenomic strategies for personalised medicine approaches, utilizing omics. Interdisciplinary and cross-sectorial collaborations are encouraged. Research projects in all disease areas are welcome. See full details in the JTC2025 call text.
Consortium
Consortia are required to be international, interdisciplinary and cross-sector. The application for intent must clearly state the personalized medicine perspective of the planned research. Companies and research organizations can participate in this call as part of an international consortium. According to the call guidelines, Business Finland can finance a maximum of two Finnish organizations from one consortium. We encourage especially companies to participate in consortia. The results of the public research project must have broad applicability in business. Depending on the Finnish organizations applying in the consortium, Business Finland uses Co-Innovation or Co-research funding services.
- Co-Innovation: Read more about the requirements. Exceptionally, one Finnish research organization and one Finnish company can form a Co-Innovation consortium in this call. Also Finnish companies and their projects applying for funding are evaluated using the Co-Innovation guidelines.
Co-Research: Read more about the requirements. Applications from a research organization (with no Finnish company in the consortium) or two research organizations are evaluated using the Co-Research guidelines. Companies that could utilize the results must contribute to the financing of the research organizations project (at least 10 % from the Finnish research organizations budget).
Please be in contact with a Business Finland contact person before sending the applications! In addition to following the JTC2024 guidelines, the applicants and projects need to follow the Business Finland funding terms and guidelines which can be found in the Business Finland website.
Preliminary schedule
The call is two-phased:
- Deadline for pre-proposal submission 18.2.2025.
- Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage (project coordinator) around May 16th.
- Deadline for full-proposal submission June 17th.
- Communication of the funding decisions to the applicants by the end of 2025.
- Expected project start end of 2025/beginning of 2026.
Finnish participants submit a separate application for Business Finland in the second phase of the call. Eligible applicants will be notified. More information about the call and Business Finland requirements:
EP Permed JTC2
Funding terms
